tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IRON Stock Latest News

FDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
Market NewsFDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
3d ago
AQST
IRON
Disc Medicine: Bitopertin’s Accelerated Approval Path and FDA Timing Support Buy Rating and $118 Target
PremiumRatings
Disc Medicine: Bitopertin’s Accelerated Approval Path and FDA Timing Support Buy Rating and $118 Target
16d ago
IRON
Reported timing of Disc Medicine review date a positive, says Morgan Stanley
PremiumThe Fly
Reported timing of Disc Medicine review date a positive, says Morgan Stanley
17d ago
IRON
Disc Medicine falls -6.8%
PremiumThe Fly
Disc Medicine falls -6.8%
17d ago
IRON
Street sees buying opportunity as Disc Medicine slips on FDA review delay
PremiumThe Fly
Street sees buying opportunity as Disc Medicine slips on FDA review delay
17d ago
LLY
SNY
Stifel sees weakness in Disc Medicine shares as buying opportunity
PremiumThe FlyStifel sees weakness in Disc Medicine shares as buying opportunity
17d ago
CHRO
IRON
FDA pushes back reviews of several fast-tracked medicines, Reuters reports
Premium
The Fly
FDA pushes back reviews of several fast-tracked medicines, Reuters reports
17d ago
LLY
SNY
Disc Medicine selloff brings buying opportunity, says Wedbush
Premium
The Fly
Disc Medicine selloff brings buying opportunity, says Wedbush
17d ago
IRON
Maintaining a Buy on IRON: Confidence in Bitopertin’s Regulatory Path, Commercial Readiness, and Broader Hematology Pipeline Upside
PremiumRatings
Maintaining a Buy on IRON: Confidence in Bitopertin’s Regulatory Path, Commercial Readiness, and Broader Hematology Pipeline Upside
19d ago
IRON
Disc Medicine names Lisa Amaya Price as Chief Human Resources Officer
PremiumThe Fly
Disc Medicine names Lisa Amaya Price as Chief Human Resources Officer
20d ago
IRON
Disc Medicine prepares for potential 2026 bitopertin FDA decision
PremiumCompany Announcements
Disc Medicine prepares for potential 2026 bitopertin FDA decision
20d ago
8K
IRON
Disc Medicine highlights recent pipeline progress, priorities for 2026
PremiumThe Fly
Disc Medicine highlights recent pipeline progress, priorities for 2026
20d ago
IRON
Disc Medicine price target raised to $120 from $115 at Morgan Stanley
PremiumThe FlyDisc Medicine price target raised to $120 from $115 at Morgan Stanley
24d ago
IRON
Jefferies sees ‘overreaction’ to article on Disc Medicine’s EPP approvability
Premium
The Fly
Jefferies sees ‘overreaction’ to article on Disc Medicine’s EPP approvability
1M ago
IRON
Disc Medicine (IRON): Constructive FDA Dialogue and APOLLO Progress Support Buy Rating Despite Volatility
Premium
Ratings
Disc Medicine (IRON): Constructive FDA Dialogue and APOLLO Progress Support Buy Rating Despite Volatility
1M ago
IRON
BMO Capital says call with Disc management clarifies active FDA dialogue
PremiumThe Fly
BMO Capital says call with Disc management clarifies active FDA dialogue
1M ago
IRON
TD Cowen says Disc Medicine remains confident, bito timeline under CNPV intact
PremiumThe Fly
TD Cowen says Disc Medicine remains confident, bito timeline under CNPV intact
1M ago
IRON
Disc Medicine falls -14.3%
PremiumThe Fly
Disc Medicine falls -14.3%
1M ago
IRON
FDA voucher program allowing White House to intervene, STAT reports
PremiumThe Fly
FDA voucher program allowing White House to intervene, STAT reports
1M ago
IRON
Disc Medicine’s Promising Position in Anemia Treatment Boosts Buy Rating Amidst Competitor Setback
PremiumRatingsDisc Medicine’s Promising Position in Anemia Treatment Boosts Buy Rating Amidst Competitor Setback
2M ago
IRON
Disc Medicine Advances Bitopertin in FDA Pilot Program
Premium
Company Announcements
Disc Medicine Advances Bitopertin in FDA Pilot Program
2M ago
8K
IRON
Evan Seigerman Recommends Buy Rating for Disc Medicine Due to Promising Phase 2 Data and Potential Stock Appreciation
Premium
Ratings
Evan Seigerman Recommends Buy Rating for Disc Medicine Due to Promising Phase 2 Data and Potential Stock Appreciation
2M ago
IRON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >